376
Participants
Start Date
May 14, 2025
Primary Completion Date
May 31, 2028
Study Completion Date
December 31, 2028
Tadalafil
Target dose 40 mg OD
Ambrisentan
Target dose 10 mg OD
Ambrisentan mimic
Ambrisentan mimic will switch to Ambrisentan if low risk status was not achived at month 4, or 8, or 12.
Tadalafil mimic
Tadalafil mimic will switch to Tadalafil if low risk status was not achived at month 4, or 8, or 12.
RECRUITING
The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou
Huzhou Central Hospital
OTHER
Ningbo Medical Center Lihuili Hospital
OTHER_GOV
First Affiliated Hospital of Ningbo University
NETWORK
Ningbo No.2 Hospital
OTHER
Affiliated Hospital of Jiaxing University
OTHER
The Second Affiliated Hospital of Jiaxing University
OTHER
First Affiliated Hospital of Wenzhou Medical University
OTHER
Shanghai Pulmonary Hospital affiliated to Tongji University
UNKNOWN
Taizhou Hospital
OTHER
Guangdong Provincial People's Hospital
OTHER
Second Affiliated Hospital, School of Medicine, Zhejiang University
OTHER